BRIEF-Dr. Reddy's Laboratories Enters Into Licensing Agreement With Gilead Sciences For Remdesivir

REDDY'S CAN REGISTER, MANUFACTURE &SELL GILEAD'S REMDESIVIR IN 127 COUNTRIES INCLUDING INDIA * DR.REDDY'S LABORATORIES LTD - CO NEED TO DO MANUFACTURING SCALE UP AND OBTAIN REGULATORY APPROVAL FOR MARKETING OF THIS DRUG IN RESPECTIVE COUNTRIES Source text for Eikon: Further company coverage:

Dr.Reddy's Laboratories Ltd: * DR. REDDY'S LABORATORIES ENTERS INTO A LICENSING AGREEMENT WITH GILEAD SCIENCES FOR REMDESIVIR

* DR.REDDY'S - ENTERED NON-EXCLUSIVE LICENSING AGREEMENT WITH GILEAD UNDER WHICH CO CAN REGISTER, MANUFACTURE &SELL GILEAD'S REMDESIVIR DRUG * DR.REDDY'S LABORATORIES LTD - WILL RECEIVE TECHNOLOGY TRANSFER FROM GILEAD FOR MANUFACTURING OF THIS DRUG

* DR.REDDY'S LABORATORIES LTD - UNDER AGREEMENT DR. REDDY'S CAN REGISTER, MANUFACTURE &SELL GILEAD'S REMDESIVIR IN 127 COUNTRIES INCLUDING INDIA * DR.REDDY'S LABORATORIES LTD - CO NEED TO DO MANUFACTURING SCALE UP AND OBTAIN REGULATORY APPROVAL FOR MARKETING OF THIS DRUG IN RESPECTIVE COUNTRIES Source text for Eikon: Further company coverage: